Luv these last two lines .....
Mayne Pharma directly markets more than 55 products and has a growing pipeline of approximately 30 products targeting US markets with IQVIA sales greater than US$5 billion.
Morningstar has 5-star "Strong Buy" rating for MYX.
I'm sure this going to be $2 in one year! MYX is awakening up!!
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma's generic NuvaRing accepted for filing by FDA
MYX
mayne pharma group limited
Add to My Watchlist
3.94%
!
$2.90
Ann: Mayne Pharma's generic NuvaRing accepted for filing by FDA, page-2
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
DBO
DIABLO RESOURCES LIMITED
Lyle Thorne, CEO
Lyle Thorne
CEO
SPONSORED BY The Market Online
